Elisabeth Sthengel

Direttore Tecnico/Scientifico/R&S presso INVENT MEDIC SWEDEN AB

Health Technology

Profilo

Elisabeth Sthengel is currently working as Manager-Design, Development & Clinical at Invent Medic Sweden AB since 2017.
Prior to this, she worked as Laboratory Manager at NOLabs AB.

Posizioni attive di Elisabeth Sthengel

Società	Posizione	Inizio
INVENT MEDIC SWEDEN AB	Direttore Tecnico/Scientifico/R&S	01/06/2017

Tutte le posizioni attive di Elisabeth Sthengel

Precedenti posizioni note di Elisabeth Sthengel

Società	Posizione	Fine
NOLabs AB NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Elisabeth Sthengel

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Elisabeth Sthengel

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
INVENT MEDIC SWEDEN AB	Health Technology

Aziende private	1
NOLabs AB NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden.	Health Technology